Expression of vascular endothelial growth factor, matrix metallaproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer

British Journal of Cancer

Volumn 80, Issue 9, 1999, Pages 1366-1372

  Sato, F ^a   Shimada, Y ^a   Watanabe, G ^a   Uchida, S ^a   Makino, T ^a   Imamura, M ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

E cadherin; Lymph node metastasis; MMP 9; Oesophageal cancer; VEGF

Indexed keywords

GELATINASE B; UVOMORULIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER STAGING; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; COLLAGENASES; ENDOTHELIAL GROWTH FACTORS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; KERATINS; LYMPHATIC METASTASIS; LYMPHOKINES; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032986716     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690530     Document Type: Article

References (40)

1. Bland KI, Konstadoulakis MM, Vezeridis MP and Wanebo HJ (1995) Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg 221: 706-720
2. Bongiorno PF, al Kasspoles M, Lee SW, Rachwal WJ, Moore JH, Whyte RI, Orringer MB and Beer DG (1995) E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. Br J Cancer 71: 166-172
3. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M. Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W and Nagy A (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439
4. Chambers AF and Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260-1270
5. Ferrara N (1996) Vascular endothelial growth factor. Eur-J-Cancer 32a: 2413-2422
6. Ferrara N, Carver Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell Braxton L, Hillan KJ and Moore MW (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442
7. Folkman J (1990) What is the evidence that tumours are angiogenesis dependent? J Natl Cancer Inst 82: 4-6
8. Gastl G, Herrmann T, Steurer M, Zmija J, Gunsiluis E, Unger C and Kraft A (1997) Angiogenesis as a target for tumour treatment. Oncology 54: 177-184
9. Ide H, Nakamura T, Hayashi K, Endo T, Kobayashi A, Eguchi R and Hanyu F (1994) Esophageal squamous cell carcinoma: pathology and prognosis. World J Surg 18: 321-330
10. Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M and Farthing MJ (1997) Abnormal immunoreactivity of the E-cadherin catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology 112: 46-54
11. Kadowaki T, Shiozaki H, Inoue M, Tamura S, Oka H, Doki Y, Iihara K, Matsui S, Iwazawa T, Nagafuchi A, et al (1994) E-cadherin and α-catenin expression in human esophageal cancer. Cancer Res 54: 291-296
12. Kawahara E, Okada Y, Nakanishi I, Iwata K, Kojima S, Kumagai S and Yamamoto E (1993) The expression of invasive behavior of differentiated squamous carcinoma cell line evaluated by an in vitro invasion model. Jpn J Cancer Res 84, 409-418
13. Kurokawa Y (1970) Experiments on lymph node metastatis by intralymphatic inoculation of rat ascites tumor cells, with special reference to lodgement, passage, and growth of tumor cells in lymph nodes. Gann 61: 461-471
14. Lerut T, De Leyn P, Coosemans W, Van Racmdonek D, Scheys I and LeSaffre E (1992) Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 216: 583-590
15. Liotta LA (1992) Cancer cell invasion and metastasis. Sci Am 266: 54 9, 62-63
16. Liotta LA and Stetler Stevenson WG (1991) Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51: 5054s-5059s
17. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T and Sowa M (1996) Prognostic value of vascular endothelial growth factor expressions in gastric carcinoma. Cancer 77: 858-863
18. Moriyama M, Kumagai S, Kawashiri S, Kojima K, Kakihara K and Yamamoto E (1997) Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Oral Oncol 33: 369-374
19. Nagashima M, Yoshino S, Ishiwata T and Asano G (1995) Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 22: 1624-1630
20. Nakanishi Y, Ochiai A, Akimoto S, Kato H, Watanabe H, Tachimori Y, Yamamoto S and Hirohashi S (1997) Expression of E-cadherin, α-catenin, β-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions. Oncology 54: 158-165
21. Ohta Y, Watanabe Y, Murakami S, Oda M, Hayashi Y, Nonomura A, Endo Y and Sasaki T (1997) Vascular endothelial growth factor and lymph node metastasis in primary lung cancer. Br J Cancer 76: 1041-1045
22. Roberts WG and Palade GE (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108: 2369-2379
23. Roder JD, Busch R, Stein HJ, Fink U and Siewert JR (1994) Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 81: 410-413
24. Rosai J (1996) Ackerman's Surgical Pathology, Vol. 1. Mosby Year Book, Inc.: St Louis, MO.
25. Schipper JH, Frisen UH, Behrens J, Unger A, Jahnke K and Birchmeier W (1991) E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 51: 6328-6337
26. Senger DR, Van de Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackman RW, Dvorak AM and Dvorak HF (1993) Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12: 303-324
27. Shigetomi A, Kotoh T, Harada T, Morikawa S and Nakamura T (1992) Development of an experimental model for spontaneous lymph node metastasis of human esophageal carcinoma in nude mice: histopathological analysis. Hum Cell 5: 273-281
28. Shima I, Sasaguri Y, Kusukawa J, Yamana H, Fujita H, Kakegawa T and Morimatsu M (1992) Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinocopathologic study. Cancer 70: 2747-2753
29. Shimada Y, Imamura M, Shibagaki I, Tanaka H, Miyahara T, Kato M and Ishizaki K (1997) Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy. Ann Surg 226: 162-168
30. Shimoyama Y, Hirohashi S, Hirano S, Noguchi M, Shimosato Y, Takeichi M and Abe O (1989) Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res 49: 2128-2133
31. Shiozaki H, Oka H, Inoue M, Tamura S and Monden M (1996) E-cadherin mediated adhesion system in cancer cells. Cancer 77: 1605-1613
32. Tanigawa N, Matsumura M, Amaya H, Kitaoka A, Shimomatsuya T, Lu C, Muraoka R and Tanaka T (1997) Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer 79: 220-225
33. Theunissen PH, Borchard F and Poortvliet DC (1991) Histopathological evaluation of oesophageal carcinoma: the significance of venous invasion. Br J Surg 78: 930-932
34. Uchida S, Shimada Y, Watanabe G, Tanaka H, Shibagaki I, Miyahara T, Ishigami S, Arii S and Imamura M (1998) In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation advanced stage and poor prognosis. Br J Cancer 77: 1704-1709
35. UICC (1997) TNM Classification of Malignant Tumours, 5th edn. John Wiley: New York
36. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura and White R (1989) Allelotype of colorectal carcinomas. Science 244: 207-211
37. Vojtesek B, Bartek J, Midgley CA and Lane DP (1992) An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 151: 237-244
38. von Wasielewski R, Rhein A, Werner M, Scheumann GF, Dralle H, Potter E, Brabant G and Georgii A (1997) Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome. Cancer Res 57: 2501-2507
39. Wang DY, Xiang YY, Tanaka M, Li XR, Li JL, Shen Q, Sugimura H and Kino I (1994) High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis [published erratum appears in Cancer 1995; 75: 1404]. Cancer 74: 3089-3096
40. Woodcock Mitchell J, Eichner R, Nelson WG and Sun TT (1982) Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol 95: 580-588